These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 30218939)

  • 1. Fecal microbiota transfer for bowel disorders: efficacy or hype?
    Schmulson M; Bashashati M
    Curr Opin Pharmacol; 2018 Dec; 43():72-80. PubMed ID: 30218939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
    Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
    Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplantation for managing irritable bowel syndrome.
    El-Salhy M; Mazzawi T
    Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):439-445. PubMed ID: 29493330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review.
    Rossen NG; MacDonald JK; de Vries EM; D'Haens GR; de Vos WM; Zoetendal EG; Ponsioen CY
    World J Gastroenterol; 2015 May; 21(17):5359-71. PubMed ID: 25954111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
    Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
    Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
    Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
    PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?
    Pinn DM; Aroniadis OC; Brandt LJ
    Neurogastroenterol Motil; 2015 Jan; 27(1):19-29. PubMed ID: 25424663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases.
    Cammarota G; Pecere S; Ianiro G; Masucci L; Currò D
    Dig Dis; 2016; 34(3):279-85. PubMed ID: 27027524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study.
    Kurokawa S; Kishimoto T; Mizuno S; Masaoka T; Naganuma M; Liang KC; Kitazawa M; Nakashima M; Shindo C; Suda W; Hattori M; Kanai T; Mimura M
    J Affect Disord; 2018 Aug; 235():506-512. PubMed ID: 29684865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.
    Huang HL; Chen HT; Luo QL; Xu HM; He J; Li YQ; Zhou YL; Yao F; Nie YQ; Zhou YJ
    J Dig Dis; 2019 Aug; 20(8):401-408. PubMed ID: 31070838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal microbiota transplantation in patients with irritable bowel syndrome: an overview of current studies.
    Körner E; Lorentz A
    J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36882216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of fecal microbiota transplantation for irritable bowel syndrome.
    El-Salhy M; Hausken T; Hatlebakk JG
    Neurogastroenterol Motil; 2021 Nov; 33(11):e14157. PubMed ID: 34236740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome.
    El-Salhy M; Casen C; Valeur J; Hausken T; Hatlebakk JG
    World J Gastroenterol; 2021 May; 27(18):2219-2237. PubMed ID: 34025075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?
    Zhou Y; Xu H; Huang H; Li Y; Chen H; He J; Du Y; Chen Y; Zhou Y; Nie Y
    Biomed Res Int; 2019; 2019():3469754. PubMed ID: 31467881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of randomized controlled trials evaluating the effectiveness of fecal microbiota transplantation for patients with irritable bowel syndrome.
    Wang Y; Hu Y; Shi P
    BMC Gastroenterol; 2024 Jul; 24(1):217. PubMed ID: 38970007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead.
    Borody T; Fischer M; Mitchell S; Campbell J
    Expert Rev Gastroenterol Hepatol; 2015; 9(11):1379-91. PubMed ID: 26414076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21
    El-Salhy M; Patcharatrakul T; Gonlachanvit S
    World J Gastroenterol; 2021 Jun; 27(22):2921-2943. PubMed ID: 34168399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation for gastrointestinal diseases.
    Matsuoka K; Mizuno S; Hayashi A; Hisamatsu T; Naganuma M; Kanai T
    Keio J Med; 2014; 63(4):69-74. PubMed ID: 25500625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysbiosis in Functional Bowel Disorders.
    Enck P; Mazurak N
    Ann Nutr Metab; 2018; 72(4):296-306. PubMed ID: 29694952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.